ACTIVIDENTITY CORP (NASDAQ: ACTI)

View Portfolio
Back to Investopedia
Back to Investopedia




$2.37 0.13 (5.80%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
3.04
52-Week Low Price
1.50
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.11 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-1.15
Shares
45.87 M
Dividend Rate ($) / (%)
0.00/0.00
100%
0%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 14% - ACTI has underperformed the S&P 500 by 12%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
SABA SOFTWARE INC (SABA) $4.50 -  $0.01(0.22%)0.13 B
AMERICAN SOFTWARE INC A (AMSWA) $5.44 -  $0.19(3.62%)0.12 B
MAGMA DESIGN AUTOMATION (LAVA) $2.32 -  $0.02(0.87%)0.12 B
CYBERDEFENDER CORP (CYDE) $4.18 -  $0.08(1.95%)0.11 B
CHORDIANT SOFTWARE INC (CHRD) $3.45 -  $0.02(0.58%)0.11 B
COREL CORPORATION (CREL) $3.98 -  $0.00(0.00%)0.10 B
COMMTOUCH SOFTWARE LTD (CTCH) $3.90 -  $0.00(0.00%)0.10 B
PAID INC (PAYD) $0.40 -  $0.02(5.33%)0.10 B
PHOENIX TECHNOLOGIES LTD (PTEC) $2.67 -  $0.05(1.91%)0.10 B
GSE SYSTEMS INC (GVP) $5.11 -  $0.09(1.79%)0.10 B
As of February 09, 2010 at 4:06 PM ET
STOCK ANALYSIS
There are currently no Stock Analysis.
ACTI RELATED HEADLINES
arrow
ActivIdentity names Grant Evans CEO, replacing Thomas Jahn

Forbes.com 4/14/2008
arrow
ActivIdentity Names Grant Evans As CEO

Forbes.com 4/14/2008
arrow
ActivIdentity Provides Revenue Range for Its Fiscal Second Quarter 2008

Forbes.com 4/11/2008
arrow
Active Biotech grants Chelsea Therapeutics full global rights to I-3D portfolio

Forbes.com 4/8/2008
arrow
ActivIdentity Announces Board Changes

Forbes.com 3/13/2008
arrow
ActivIdentity CFO to resign in May

Forbes.com 3/13/2008
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2